Monolithic, I appreciate your reponse. 

However, a quick historic review of the companies I mentioned, which are also the ones you posted from the Bloomburg resume, shows no billion dollar financial upswings, either in the company as a whole or a division of those three companies, during the time that Suresh was employed by them.

Perhaps it was a misunderstanding of a statement attributed to a time period some 3 years past.

Regardless, the point is not to be argumentive, but rather to provide accuracy.

No matter what did or didn't occur in the past, the concensus today is that the good doctor is the right person at the right time to steer PoET to commercialization. Yes?